Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers

NCT02572089 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Drug Overdose
Opioid-Related Disorders

Interventions

DRUG: Naloxone

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators

[object Object]